For informational purposes only — not investment advice

← Back to signals

SPRB

Spruce Biosciences, Inc.

Research: Finviz ↗·Perplexity ↗

No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.

Days to cover (short int.)
7.0d↑+23.1%
as of 2026-10-30 · shares short vs 2026-09-30

Fund 13D/13G Filings (3)

Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).

FundForm∆ Shares% of ClassSince FilingFiledSrc
Citadel AdvisorsSC 13G/A−18K1.9%
-16.3% vs SPY
-18.5% abs
2026-08-14↗
Citadel AdvisorsSC 13G/A—5.1%
-13.0% vs SPY
-7.5% abs
2026-05-15↗
Citadel AdvisorsSC 13G/A—6.5%—2026-02-17↗

Tracked Funds Holding (1)

FundManagerShares HeldPosition Value
Point72Steve Cohen44K$2M

Quarter-end 13F positions for the tracked funds holding this stock.